Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Stempoint Capital LP reported a 8.20% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Stempoint Capital LP reported a 8.20% stake in Vistagen Therapeutics, Inc., 2,328,492 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 2,328,492
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| StemPoint Capital LP | 8.20% | 2,328,492 |
| StemPoint Capital Management GP LLC | 8.20% | 2,328,492 |
| Michelle Ross | 8.20% | 2,328,492 |
Source
Related
- Vistagen Therapeutics, Inc.
- Stempoint Capital LP
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Stempoint Capital LP · Feb 17, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026